Press release
May 1, 2026
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
Seaport Therapeutics, Inc. (SPTX)
BOSTON --(BUSINESS WIRE)--Apr. 30, 2026-- Seaport Therapeutics, Inc., (Nasdaq: SPTX) (“Seaport” or the “Company”), a clinical-stage therapeutics company that is inventing and developing neuropsychiatric medicines, today announced the pricing of its upsized initial public offering of 14,160,000